New generic drug tested against dangerous fungal infections
NCT ID NCT07239765
Summary
This study tested the safety and effectiveness of a generic version of an antifungal medicine in adults with serious mold infections. Researchers tracked side effects and how well patients responded to treatment over several weeks. The goal was to see if this generic drug could help control these severe infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE MOLD DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, China
Conditions
Explore the condition pages connected to this study.